Flutemetamol (18F)

Revision as of 22:41, 14 April 2015 by Rabin Bista (talk | contribs) (Created page with "{{DISPLAYTITLE:Flutemetamol (<sup>18</sup>F)}} {{Infobox drug | drug_name = Flutemetamol (<sup>18</sup>F) | IUPAC_name = 2-[3-(<sup>18</sup>F)Fluoro-4-(methylam...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Flutemetamol (18F)
Clinical data
Trade namesVizamyl
AHFS/Drugs.comMicromedex Detailed Consumer Information
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
Intravenous
ATC code
Legal status
Legal status
Identifiers
PubChem CID
ChemSpider
UNII
ChEBI
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC14H1118FN2OS
Molar mass273.316 g/mol
3D model (JSmol)

WikiDoc Resources for Flutemetamol (18F)

Articles

Most recent articles on Flutemetamol (18F)

Most cited articles on Flutemetamol (18F)

Review articles on Flutemetamol (18F)

Articles on Flutemetamol (18F) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Flutemetamol (18F)

Images of Flutemetamol (18F)

Photos of Flutemetamol (18F)

Podcasts & MP3s on Flutemetamol (18F)

Videos on Flutemetamol (18F)

Evidence Based Medicine

Cochrane Collaboration on Flutemetamol (18F)

Bandolier on Flutemetamol (18F)

TRIP on Flutemetamol (18F)

Clinical Trials

Ongoing Trials on Flutemetamol (18F) at Clinical Trials.gov

Trial results on Flutemetamol (18F)

Clinical Trials on Flutemetamol (18F) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Flutemetamol (18F)

NICE Guidance on Flutemetamol (18F)

NHS PRODIGY Guidance

FDA on Flutemetamol (18F)

CDC on Flutemetamol (18F)

Books

Books on Flutemetamol (18F)

News

Flutemetamol (18F) in the news

Be alerted to news on Flutemetamol (18F)

News trends on Flutemetamol (18F)

Commentary

Blogs on Flutemetamol (18F)

Definitions

Definitions of Flutemetamol (18F)

Patient Resources / Community

Patient resources on Flutemetamol (18F)

Discussion groups on Flutemetamol (18F)

Patient Handouts on Flutemetamol (18F)

Directions to Hospitals Treating Flutemetamol (18F)

Risk calculators and risk factors for Flutemetamol (18F)

Healthcare Provider Resources

Symptoms of Flutemetamol (18F)

Causes & Risk Factors for Flutemetamol (18F)

Diagnostic studies for Flutemetamol (18F)

Treatment of Flutemetamol (18F)

Continuing Medical Education (CME)

CME Programs on Flutemetamol (18F)

International

Flutemetamol (18F) en Espanol

Flutemetamol (18F) en Francais

Business

Flutemetamol (18F) in the Marketplace

Patents on Flutemetamol (18F)

Experimental / Informatics

List of terms related to Flutemetamol (18F)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Flutemetamol (18F) (trade name Vizamyl, by GE Healthcare) is a PET scanning radiopharmaceutical containing the radionuclide fluorine-18, used as a diagnostic tool for Alzheimer's disease.[1]

Mechanism of action

After the substance is given intravenously, it accumulates in beta amyloid plaques in the patient's brain, which thus become visible via positron emission tomography (PET).[1]

References

  1. 1.0 1.1 H. Spreitzer (18 August 2014). "Neue Wirkstoffe – Flutemetamol". Österreichische Apothekerzeitung (in German) (17/2014): 43.

Template:Diagnostic radiopharmaceuticals

Template:Pharma-stub